1. Home
  2. CNEY vs GNPX Comparison

CNEY vs GNPX Comparison

Compare CNEY & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNEY
  • GNPX
  • Stock Information
  • Founded
  • CNEY 2018
  • GNPX 2009
  • Country
  • CNEY China
  • GNPX United States
  • Employees
  • CNEY N/A
  • GNPX N/A
  • Industry
  • CNEY Major Chemicals
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNEY Industrials
  • GNPX Health Care
  • Exchange
  • CNEY Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • CNEY 1.0M
  • GNPX 854.2K
  • IPO Year
  • CNEY 2021
  • GNPX 2018
  • Fundamental
  • Price
  • CNEY $0.28
  • GNPX $0.91
  • Analyst Decision
  • CNEY
  • GNPX Strong Buy
  • Analyst Count
  • CNEY 0
  • GNPX 1
  • Target Price
  • CNEY N/A
  • GNPX $10.00
  • AVG Volume (30 Days)
  • CNEY 9.5M
  • GNPX 877.2K
  • Earning Date
  • CNEY 01-01-0001
  • GNPX 11-13-2024
  • Dividend Yield
  • CNEY N/A
  • GNPX N/A
  • EPS Growth
  • CNEY N/A
  • GNPX N/A
  • EPS
  • CNEY N/A
  • GNPX N/A
  • Revenue
  • CNEY $66,509,375.00
  • GNPX N/A
  • Revenue This Year
  • CNEY N/A
  • GNPX N/A
  • Revenue Next Year
  • CNEY N/A
  • GNPX N/A
  • P/E Ratio
  • CNEY N/A
  • GNPX N/A
  • Revenue Growth
  • CNEY 35.10
  • GNPX N/A
  • 52 Week Low
  • CNEY $0.26
  • GNPX $0.28
  • 52 Week High
  • CNEY $2.25
  • GNPX $14.40
  • Technical
  • Relative Strength Index (RSI)
  • CNEY 39.46
  • GNPX 41.51
  • Support Level
  • CNEY $0.27
  • GNPX $0.82
  • Resistance Level
  • CNEY $0.36
  • GNPX $1.26
  • Average True Range (ATR)
  • CNEY 0.06
  • GNPX 0.10
  • MACD
  • CNEY -0.00
  • GNPX -0.01
  • Stochastic Oscillator
  • CNEY 1.42
  • GNPX 20.45

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: